The Horizon Europe Cancer Mission Call 2026 funds bold, collaborative projects aimed at advancing cancer prevention, early detection, clinical trials, digital health, and equitable cancer care. Topics include Virtual Human Twin models, microbiome-based early prediction, pragmatic immunotherapy trials, enhanced palliative care, survivor mental health, and cancer resilience programs. It offers a unique opportunity for multidisciplinary teams across Europe and eligible non-EU countries to contribute to Europe’s transformative cancer research mission.
Eligibility Criteria:
- Research consortia comprising institutions in EU Member States or Horizon Europe Associated Countries.
- Projects must align with at least one Cancer Mission topic.
- Inclusion of clinical, academic, NGO, or industry partners is encouraged.
- At least one participant must be based in a Horizon Europe-associated country.
Funding Details:
- Calls funded under Horizon Europe (2021–2027); total programme >€14 billion (Health cluster).
- Specific budget per topic varies (consult Funding & Tenders Portal).
- Modular funding covers research activities, personnel, technology, and collaborative costs.
Deadline:
- Deadline for proposal submission: 15 September 2026, 17:00 CEST
Where to go for further information:
- Funding & Tenders Portal: Cancer Mission calls 2026